http://www.fpnotebook.com/
Bismuth SubsalicylateAka: Pepto-Bismol
- Indications
- Traveler's Diarrhea
- Helicobacter Pylori management
- Dosing
- Tablet: Two tabs PO qid up to maximum of every 4 hours
- Liquid: 30 ml every 30 minutes to maximum of 240 ml/day
- Adverse Effects
- Turns Tongue and stool black
- Mild Tinnitus
- May decrease bioavailability of Doxycycline
- Doxycycline is used for Malaria Prophylaxis
- Contraindications
- Avoid in Salicylate allergy
- Avoid if patient on Salicylates OR Coumadin
- Do not exceed 3 weeks of use
bismuth subsalicylate (C0053792) | |
|---|---|
| Definition (PDQ) | A bismuth salt of salicylic acid. Little absorbed from the gastrointestinal tract, bismuth subsalicylate exerts a local effect on the gastric mucosa, coating it and protecting it from the corrosive effects of acid and pepsin. This agent also has local antimicrobial properties. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42311&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42311&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1020" NCI Thesaurus) |
| Definition (NCI) | A bismuth salt of salicylic acid. Little absorbed from the gastrointestinal tract, bismuth subsalicylate exerts a local effect on the gastric mucosa, coating it and protecting it from the corrosive effects of acid and pepsin. This agent also has local antimicrobial properties. (NCI04) |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| English | bismuth subsalicylate, BISMUTH SUBSALICYLATE PREPARATION, subsalicylate bismuth |
| Spanish | subsalicilato de bismuto |
| Credits | Derived from the NIH UMLS (Unified Medical Language System) |
